| Application no. and date | 22733341.6 (espacenet) (Federated) (European Patent Register), 20220607 | | Patent/reg. no. and date | DK/EP 4351582, 20251008 | | Publication date | 20240417 | | Priority no. and date | EP 21178462, 20210609, EP 22157499, 20220218 | | EP pub. no. and date |
EP 4351582 20240417 | | Effective date | | | Applicant/owner | F. Hoffmann-La Roche AG, Grenzacherstrasse 124
4070 Basel, CH | | Applicant ref. no. | | | Inventor | WICHMANN, Juergen,
4070 Basel, CH,
PETTAZZONI, Piergiorgio Francesco Tommaso,
4070 Basel, CH,
ECKMANN, Jan,
82377 Penzberg, DE,
FRIESS, Thomas,
82377 Penzberg, DE,
HERTING, Frank,
82377 Penzberg, DE | | Representative | | | Opponent | | | IPC Class | A61K 31/517 (2006.01) , A61K 39/395 (2006.01) , A61K 45/06 (2006.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) | | Title | COMBINATION OF A PARTICULAR BRAF INHIBITOR (PARADOX BREAKER) AND A PD-1 AXIS BINDING ANTAGONIST FOR USE IN THE TREATMENT OF CANCER | | Int. application no. | EP2022065373 | | Int. publication no. | WO2022258600 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
